A number of long-term prescription policies have been released this year, and prescription sinking will accelerate

Long-term prescriptions are suitable for patients with chronic diseases with clear clinical diagnosis, stable medication regimen, good compliance, stable disease control, and long-term drug treatment
.
In recent years, with the rapid increase in the number of chronic patients and the increasing demand for long-term prescriptions, the country and localities have also begun to actively explore and implement long-term prescription policies
.
It is understood that under the promotion of national policies, Zhejiang, Guangdong, Beijing, Shanghai and other places have already begun to explore long-term prescription policies for patients with chronic diseases, and they have been generally welcomed by patients
.
For example, in April 2018, the General Office of the Zhejiang Provincial Government issued the "Action Plan for Deepening the "Maximum Run Once" Reform in the Medical and Health Services Sector in Zhejiang Province", and the chronic disease continuous prescription system has become one of the top ten reform measures in the field of medical and health care.

.
Later, various prefectures and cities across the province also introduced specific measures
.
In addition, Zhejiang Province has also clarified the scope of long-term prescription diseases, and identified 12 provincial chronic diseases such as hypertension, diabetes, and Alzheimer's disease
.
Localities can add special (regulated) types of chronic diseases on their own, and contract family doctors will issue long-term prescriptions to unify the drug catalogs supplied by county-level hospitals and township health centers within the county
.
Nowadays, Zhejiang Province has been implementing a long-term prescription system for chronic diseases for more than three years.
The problems of difficult and undispensable medicines at the grassroots level have been alleviated, and it has been generally welcomed by patients with chronic diseases
.
It is worth noting that since this year, the relevant state departments have issued a number of long-term prescription policies
.
For example, in March, the National Health Commission issued the "Notice on Doing a Good Job in the Management of Long-term Prescriptions for Chronic Diseases", requesting the strengthening of daily medical service management, and encouraging the formulation and improvement of long-term prescription management policies for patients with chronic diseases based on local conditions.
, Clarify the list of diseases that can be prescribed for long-term prescriptions, scope of medication, management system, safety notification and other requirements, so as to reduce the number of patients taking medication
.
The notice provides convenience for the diagnosis and treatment of patients with chronic diseases, but also provides opportunities for proprietary Chinese medicines focusing on the treatment of chronic diseases.

.
In April, the National Health Commission also organized the drafting of the "Long-term Prescription Management Standards (Trial Draft for Solicitation of Comments)", which aims to standardize long-term prescription management, promote hierarchical diagnosis and treatment, ensure medical quality and safety, and ensure the long-term medication needs of patients with chronic diseases
.
One of the provisions clearly stipulates that after a doctor has issued a long-term prescription, the patient can independently choose to dispense the medicine at a medical institution or social retail pharmacy
.
The industry generally believes that this new regulation is good for the pharmacy industry, especially offline pharmacies that benefit from prescription outflows and are expected to continue high performance
.
In August, the General Office of the National Health Commission and the Office of the National Medical Insurance Administration issued the "Notice on Printing and Distributing Long-term Prescription Management Standards (Trial)", proposing to implement a long-term prescription policy for eligible patients with chronic diseases.
Long-term prescriptions for chronic diseases can be prescribed, and the prescription amount is generally within 4 weeks, not more than 12 weeks
.
The industry believes that the long prescription policy is conducive to increasing compliance with drug use
.
According to the current requirements of the National Health Commission, it is encouraging localities to clarify the list of diseases that can be prescribed for long-term prescriptions, the scope of medication, and the management system.
This means that more provinces and cities will issue relevant documents in the future.
Promote the management and development of long-term prescriptions
.
With the continuous roll-out of the long-term prescription policy and the continuous advancement of the hierarchical diagnosis and treatment policy, prescription sinking will accelerate
.
The industry believes that in the future, pharmaceutical companies and pharmacies need to actively adjust their strategies to seize this wave of market dividends
.